Trending Now
Chromadex Corp (NASDAQ:CDXC) Achieves A 3.5 Day Reduction In Recovery In...
Chromadex Corp (NASDAQ:CDXC) demonstrated a 3.5-day reduction in recovery in Phase 3 clinical trial of moderate to mild coronavirus patients administered with combined metabolic...
Pfizer Inc. (NYSE: PFE) Seeking US Approval for COVID-19 Vaccine In...
In the coming weeks, children below 12 years will be able to receive COVID-19 vaccines as Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ:...
Kintara Therapeutics (NASDAQ: KTRA) Posted Net Loss of $1.6 Per Share...
Kintara Therapeutics (NASDAQ: KTRA) has announced its financial results for the fiscal year ending June 30, 2021, and offered a corporate update.
Corporate update
Recently the...
Popular News
Pharmacy Services Back on the Radar (MDRX, WBA, RXMD, CVS)
The big step from here is an improvement and normalization in terms of our relationship with healthcare. But, because of what we have all...
MAKE IT MODERN
LATEST REVIEWS
Amarin Corporation plc (NASDAQ:AMRN) is Playing the Next Game
The story right now for Amarin
Corporation plc (NASDAQ:AMRN) continues to be one of our favorites. It
represents the best of the dream that...
MAKE IT MODERN
PERFORMANCE TRAINING
Vaxart Inc. (NASDAQ:VXRT) to Commence Phase Two Study Of Its Oral VXA-CoV2-1 Vaccine In...
Vaxart Inc. (NASDAQ:VXRT) has announced plans to commence the first, second phase study of VXA-CoV2-1, its oral COVID-19 vaccine candidate, in Q2 2020. The...
Sugarmade Inc (OTCMKTS:SGMD) Could See Election Tailwind as Model Expands
As we have been noting, the big winner this election is Cannabis.
Voters moved to legalize weed in Arizona, Montana, New Jersey, and South Dakota....
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Commences ORLADEYO Shipment to US Patients for HAE Attacks Treatment
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) has announced that ORLADEYO™ (berotralstat) has received FDA approval and the company will start shipments to US patients...
Aptose Biosciences (NASDAQ:APTO) Announce Dosing of First AML Patient In CG-806 Study
Aptose Biosciences Inc. (NASDAQ:APTO) has announced the dosing of the first acute myeloid leukemia (AML) patient in Phase 1 a/b CG-806 clinical study.
CG-806 inhibits...
Earnings from Kohls (KSS) and Home Depot (HD) knocked a lot of wind out...
Markets started off with a gap higher but quickly rolled over until 11:00 a.m. Earnings from Kohls (KSS) and Home Depot (HD)...
MAKE IT MODERN
POPULAR
[/tdc_zone]